133 related articles for article (PubMed ID: 10217613)
1. Development of a rubella virus DNA vaccine.
Pougatcheva SO; Abernathy ES; Vzorov AN; Compans RW; Frey TK
Vaccine; 1999 Apr; 17(15-16):2104-12. PubMed ID: 10217613
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.
Cusi MG; Valassina M; Bianchi S; Wunner W; Valensin PE
Virus Res; 1995 Aug; 37(3):199-208. PubMed ID: 8533457
[TBL] [Abstract][Full Text] [Related]
3. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
[TBL] [Abstract][Full Text] [Related]
4. Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.
Callagy SJ; Kelly BJ; Fleeton MN; Sheahan BJ; Galbraith SE; Atkins GJ
Vaccine; 2007 Oct; 25(43):7481-90. PubMed ID: 17905485
[TBL] [Abstract][Full Text] [Related]
5. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
[TBL] [Abstract][Full Text] [Related]
6. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.
Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK
Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691
[TBL] [Abstract][Full Text] [Related]
8. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.
Forns X; Emerson SU; Tobin GJ; Mushahwar IK; Purcell RH; Bukh J
Vaccine; 1999 Apr; 17(15-16):1992-2002. PubMed ID: 10217599
[TBL] [Abstract][Full Text] [Related]
9. [Molecular and biologic characteristics of attenuated rubella viruses].
Lavrent'eva IN
Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):55-9. PubMed ID: 18819408
[TBL] [Abstract][Full Text] [Related]
10. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
Stasíková J; Kutinová L; Smahel M; Nĕmecková S
Acta Virol; 2003; 47(1):1-10. PubMed ID: 12828337
[TBL] [Abstract][Full Text] [Related]
11. Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.
Shinoda K; Wyatt LS; Irvine KR; Moss B
Virol J; 2009 Mar; 6():28. PubMed ID: 19257896
[TBL] [Abstract][Full Text] [Related]
12. Study of rubella candidate vaccine based on a structurally modified plant virus.
Trifonova EA; Zenin VA; Nikitin NA; Yurkova MS; Ryabchevskaya EM; Putlyaev EV; Donchenko EK; Kondakova OA; Fedorov AN; Atabekov JG; Karpova OV
Antiviral Res; 2017 Aug; 144():27-33. PubMed ID: 28511994
[TBL] [Abstract][Full Text] [Related]
13. Maturation of IgG avidity to individual rubella virus structural proteins.
Nedeljkovic J; Jovanovic T; Oker-Blom C
J Clin Virol; 2001 Aug; 22(1):47-54. PubMed ID: 11418352
[TBL] [Abstract][Full Text] [Related]
14. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
Qiu Z; Tufaro F; Gillam S
Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide sequence of the 24S subgenomic messenger RNA of a vaccine strain (HPV77) of rubella virus: comparison with a wild-type strain (M33).
Zheng DX; Dickens L; Liu TY; Nakhasi HL
Gene; 1989 Oct; 82(2):343-9. PubMed ID: 2583526
[TBL] [Abstract][Full Text] [Related]
16. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.
Colombage G; Hall R; Pavy M; Lobigs M
Virology; 1998 Oct; 250(1):151-63. PubMed ID: 9770429
[TBL] [Abstract][Full Text] [Related]
17. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
Golden JW; Josleyn MD; Hooper JW
Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.
Chaye HH; Mauracher CA; Tingle AJ; Gillam S
J Clin Microbiol; 1992 Sep; 30(9):2323-9. PubMed ID: 1383269
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
Wen H; Wang Z
Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
